Silexion Therapeutics Corp Cash And Cash Equivalents At Carrying Value

Quick Answer

Silexion Therapeutics Corp reported Cash And Cash Equivalents At Carrying Value of $5.99 million for the year ending 2025.

  • Silexion Therapeutics Corp showed an increase of +404.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Silexion Therapeutics Corp's annual report (Form 10-K), filed with the SEC on March 17, 2026.
  • XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2023 to 2025), Silexion Therapeutics Corp's Cash And Cash Equivalents At Carrying Value has grown by 30.4%.
  • Historical annual values: Fiscal year 2025: $5.99 million | Fiscal year 2024: $1.19 million | Fiscal year 2023: $4.60 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: